|
|
Enron Mail |
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-From: emaildelivery@businesswire.com X-To: TX-INDUSTRIAL-INFO-RES@businesswire.com X-cc: X-bcc: X-Folder: \ExMerge - Thomas, Paul D.\Deleted Items X-Origin: THOMAS-P X-FileName: paul d thomas 6-26-02.PST Welcome to eMail News Delivery, a service from Business Wire. Here is your Industrial Information Resources Inc. news release. If you have received this in error please send a message to: eMailDelivery@businesswire.com with the following command in the body of the message: unsubscribe TX-INDUSTRIAL-INFO-RES If you have questions about this service, please contact your Business Wire Account Executive or service@businesswire.com BW2004 JAN 30,2002 2:00 PACIFIC 05:00 EASTERN ( BW)(TX-INDUSTRIAL-INFO-RES) Quebec Emerges As Key Location for New Pharmaceutical and Biotech Plants, in an Advisory by Industrialinfo.com Business Editors & Health/Medical Writers HOUSTON--(BUSINESS WIRE)--Jan. 30, 2002--Researched by Industrialinfo.com (Industrial Information Resources, Inc.; Houston, Texas). The Canadian province of Quebec is successfully courting new capital investment from pharmaceutical and biotech companies worldwide. In the past year, over $300 million in new capital projects were announced. Quebec is not only seeking established international companies; they are also "hatching" them on a regular basis from their strong Biotech City, located in Laval, Quebec. Biotech City is already home to about 30 biotechnology, biopharmaceutical and information technology companies and research centers. INRS-Institut Armand Frappier, the host of Biotech City, is spending over $100 million to add new R&D laboratory space and upgrade existing facilities. Offering a host of attractions, including lucrative government incentives and a strong intellectual property base at the universities, Quebec is emerging as a major player in both research and development and the manufacturing of pharmaceuticals and biotech products. Gone are the hints of outsiders being shunned for not being French. Clever marketing efforts now promote that deep European flavor coupled with a desirable North American location. Those efforts are paying off. The roster of companies investing in new or expanded facilities is growing every year. Industrial Information Resources (IIR) is tracking these companies. Merck Frosst Canada & Company (Kirkland, Quebec) is in the midst of a $250 million expansion and modernization program at their Kirkland, Quebec site. Pharmascience Incorporated (Montreal, Quebec) recently completed a $50 million expansion at their Montreal facility. Quebec is also under serious consideration by two international pharmaceutical companies for new plant investment at a combined cost of almost $1 billion. IIR tracks project spending trends in the Pharmaceutical-Biotech industry and has recently released the 2002 US Pharmaceutical-Biotech Industry Forecast (http://www.industrialinfo.com/2002pharmforecast.htm) Industrialinfo.com provides daily news related to the industrial market place including industry alerts and databases for the energy and industrial markets. For more information on trends and upcoming construction activities in the Pharmaceutical-Biotech markets as well as other industrial sectors send inquiries to pharmabiotech@industrialinfo.com or visit us at www.industrialinfo.com. --30--MJB/ho* CONTACT: Industrial Information Resources, Houston Annette Kreuger, 713/783-5147 KEYWORD: TEXAS INTERNATIONAL CANADA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL PHARMACEUTICAL SOURCE: Industrial Information Resources For the best viewing of the news releases please use the following email settings: Courier 10 point. -Notice of Copyright and General Disclaimer- © 2000 Business Wire. All of the releases provided by Business Wire are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire`s members who are solely responsible for their content, accuracy and originality. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission. - Notice of Copyright and General Disclaimer -- © 1999 Business Wire. All of the releases provided by Business Wire are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire`s members who are solely responsible for their content, accuracy and originality. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission. - Notice of Copyright and General Disclaimer -- © 1999 Business Wire. All of the releases provided by Business Wire are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire`s members who are solely responsible for their content, accuracy and originality. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission.
|